Some studies reported that MAD2L1 and CCNB2 are highly expressed in gastric cancer, liver cancer, lung cancer, and other types of cancers; thus, they possibly serve as tumour-promoting genes [51–55], which are consistent with our immunohistochemical results. This evidence concerns the gene MAD2L1 and liver cancer.